Mitchell Levine
2018
In 2018, Mitchell Levine earned a total compensation of $873.3K as Chief Financial Officer at Oncocyte Corp, a 39% increase compared to previous year.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Option Awards | $359,287 |
| Salary | $314,008 |
| Total | $873,295 |
Levine received $359.3K in option awards, accounting for 41% of the total pay in 2018.
Levine also received $200K in bonus and $314K in salary.
Rankings
In 2018, Mitchell Levine's compensation ranked 9,809th out of 14,244 executives tracked by ExecPay. In other words, Levine earned more than 31.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,809 out of 14,244 | 31st |
Division Manufacturing | 3,960 out of 5,759 | 31st |
Major group Chemicals And Allied Products | 1,486 out of 2,122 | 30th |
Industry group Drugs | 1,251 out of 1,811 | 31st |
Industry In Vitro and In Vivo Diagnostic Substances | 40 out of 72 | 44th |
Source: SEC filing on June 18, 2019.
Levine's colleagues
We found two more compensation records of executives who worked with Mitchell Levine at Oncocyte Corp in 2018.